Berberine-stimulated glucose uptake in L6 myotubes involves both AMPK and p38 MAPK.
about
Berberine improves glucose metabolism through induction of glycolysisTraditional chinese medicine in treatment of metabolic syndromeThe antihyperglycemic effects of Rhizoma Coptidis and mechanism of actions: a review of systematic reviews and pharmacological researchModulation of glucose transporter protein by dietary flavonoids in type 2 diabetes mellitusBerberine improves glucose metabolism in diabetic rats by inhibition of hepatic gluconeogenesisBMS309403 stimulates glucose uptake in myotubes through activation of AMP-activated protein kinaseShizukaol D isolated from Chloranthus japonicas inhibits AMPK-dependent lipid content in hepatic cells by inducing mitochondrial dysfunction17-β Oestradiol prevents cardiovascular dysfunction in post-menopausal metabolic syndrome by affecting SIRT1/AMPK/H3 acetylationCinnamon extract enhances glucose uptake in 3T3-L1 adipocytes and C2C12 myocytes by inducing LKB1-AMP-activated protein kinase signalingSmall molecule antagonizes autoinhibition and activates AMP-activated protein kinase in cells.High-throughput assay for modulators of mitochondrial membrane potential identifies a novel compound with beneficial effects on db/db miceEJE PRIZE 2017: Hypothalamic AMPK: a golden target against obesity?Activation of the AMP-activated protein kinase-p38 MAP kinase pathway mediates apoptosis induced by conjugated linoleic acid in p53-mutant mouse mammary tumor cells.Quercetin, a Lead Compound against Type 2 Diabetes Ameliorates Glucose Uptake via AMPK Pathway in Skeletal Muscle Cell Line.AMPK activation: a therapeutic target for type 2 diabetes?Atrogin-1 affects muscle protein synthesis and degradation when energy metabolism is impaired by the antidiabetes drug berberine.Activation of AMP-activated protein kinase is required for berberine-induced reduction of atherosclerosis in mice: the role of uncoupling protein 2.Therapeutic potential of nucleic acid-binding isoquinoline alkaloids: binding aspects and implications for drug design.Antidiabetic activity of Pterospermum acerifolium flowers and glucose uptake potential of bioactive fraction in L6 muscle cell lines with its HPLC fingerprint.Berberine improves lipid dysregulation in obesity by controlling central and peripheral AMPK activity.Berberine regulated Gck, G6pc, Pck1 and Srebp-1c expression and activated AMP-activated protein kinase in primary rat hepatocytes.Berberine ameliorates nonalcoholic fatty liver disease by a global modulation of hepatic mRNA and lncRNA expression profilesBerberine Reduces cAMP-Induced Chloride Secretion in T84 Human Colonic Carcinoma Cells through Inhibition of Basolateral KCNQ1 Channels.Antioxidant and anti-inflammatory activities of berberine in the treatment of diabetes mellitus.Small molecule adenosine 5'-monophosphate activated protein kinase (AMPK) modulators and human diseasesApplication of berberine on treating type 2 diabetes mellitus.Fermentation, Isolation, Structure, and antidiabetic activity of NFAT-133 produced by Streptomyces strain PM0324667Berberine protects against high fat diet-induced dysfunction in muscle mitochondria by inducing SIRT1-dependent mitochondrial biogenesis.AMPK, a metabolic sensor, is involved in isoeugenol-induced glucose uptake in muscle cells.Fructus mume formula in the treatment of type 2 diabetes mellitus: a randomized controlled pilot trial.Update on berberine in nonalcoholic Fatty liver disease.Cancer prevention and therapy through the modulation of the tumor microenvironment.Anti-inflammatory activity of N-(3-florophenyl)ethylcaffeamide in miceSodium caprate augments the hypoglycemic effect of berberine via AMPK in inhibiting hepatic gluconeogenesis.Insulin resistance and fuel homeostasis: the role of AMP-activated protein kinase.The crosstalk between Nrf2 and AMPK signal pathways is important for the anti-inflammatory effect of berberine in LPS-stimulated macrophages and endotoxin-shocked mice.Quercetin reduces obesity-associated ATM infiltration and inflammation in mice: a mechanism including AMPKα1/SIRT1.Antidiabetic properties of berberine: from cellular pharmacology to clinical effects.Berberine on metabolic and cardiovascular risk factors: an analysis from preclinical evidences to clinical trials.Advances in the development of AMPK-activating compounds.
P2860
Q24642953-D860B2E3-3D20-4A64-8E66-2CD346240058Q24657961-E5948AD5-6861-42AF-8D92-0815E82213A3Q26851917-60EDD171-9868-4E39-A89B-2449D3FC9FEFQ28081094-8F39B390-33E8-4F09-AEDD-FD43D1B4A254Q28477076-72BD682D-8815-457D-B703-68A3E1D6435EQ28483273-F80C7506-A5B4-41E4-BBDB-88FB25E0E45FQ28535328-AE0870A3-01A5-49B8-B4F9-4E65A4390072Q28582839-43E036D3-7895-4478-A2D8-D18AA8D6A88CQ28659092-0BE8B285-BDCC-4DD5-BC48-0F54CCBB292CQ33322641-03BB6504-DE27-4304-AEE0-5A3F3D57D936Q33556580-D31454A7-2A9C-49B6-BB0C-B87DC0D9207FQ33660008-75B5BF60-AEA0-4D28-8871-17EE9ADEF1A9Q33727103-DE2B3404-90D8-4F95-835B-5045B0A8F6F7Q33774651-ED521E71-1082-4A49-B903-8A73D8BF0765Q33824564-79BD6E16-056B-4EF5-A75A-049FC93F68F8Q34024390-4EA9DC65-3ADE-4BD1-A7B1-BCA7FC00A322Q34043189-CF2D0E8D-8B1F-4737-A78D-40C89E852366Q34093038-0F52C630-3219-4A1C-BC1E-0E87BC42C5B7Q34461266-F0385055-36A2-472B-9D7F-DF9728737D76Q34603754-48291F6D-7E68-40B8-A493-72903089E17FQ35022545-C0E2983C-4060-4948-81EF-447FB928B0B5Q35047942-BCB076E7-9814-4A22-B002-B0E101158F7BQ35084796-65195059-A1DE-4789-9AAA-4C2EC6DEBAD0Q35145862-B1FC11D8-DB4E-474C-B699-FE8BC7E76561Q35224775-FECA4F6C-3966-4D8F-9D47-D6B5630755B2Q35226998-BE744931-E88D-4B86-B4C0-67BA136AAC77Q35742182-A45E31D2-597B-49AB-9BAD-165959A6E35AQ36006541-FE6D2EA8-2685-4B81-9185-E23B35E38B8BQ36442786-3F668C07-0A6D-4B06-AAF6-5967D0399ADEQ36711563-28A7AAF0-5727-4E6F-8385-69D16B7A9079Q36988577-9E5C4F39-BDDB-4497-A82D-B94F0506A9D6Q37058267-BEDB4F0B-F304-4388-AA45-2635221407CBQ37139014-BD38C4DF-8DA5-4BDD-A9FC-9A71C4303FE5Q37227111-ABF7F4A0-4E10-407C-BF8B-CA662E88D627Q37401940-4C3333DD-E651-49EA-AC1E-E91DD21DF326Q37513209-114AB751-0C5E-43E5-A037-5681B1D919ACQ37603203-B97B9F56-9B11-4987-834D-669E2B32BD5AQ38012073-08BA2C37-7D82-478D-A273-DB3E77B4BA5FQ38025153-8BA2D4D9-C7A4-4E96-A501-7957CEFE6AE8Q38089174-7DA85157-38E5-4A7C-9B51-6276B6B9EA95
P2860
Berberine-stimulated glucose uptake in L6 myotubes involves both AMPK and p38 MAPK.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Berberine-stimulated glucose uptake in L6 myotubes involves both AMPK and p38 MAPK.
@en
type
label
Berberine-stimulated glucose uptake in L6 myotubes involves both AMPK and p38 MAPK.
@en
prefLabel
Berberine-stimulated glucose uptake in L6 myotubes involves both AMPK and p38 MAPK.
@en
P2093
P1476
Berberine-stimulated glucose uptake in L6 myotubes involves both AMPK and p38 MAPK.
@en
P2093
An-Hui Gao
Chuan-Ming Xie
Fa-Jun Nan
Jing-Ya Li
P304
P356
10.1016/J.BBAGEN.2006.09.007
P577
2006-09-20T00:00:00Z